Aimee Simonetti

Selected to return as an inaugural member and help shape the new Alzheimer's Business Unit to reengage key Neurology and Imaging stakeholders across OH/WV by increasing adoption of the diagnostic tracer AMYViD and prepare the ecosystem for the revolutionary launch of the new disease-modifying therapy Kisunla. Lead launch efforts with cross-functional partners within LVA, Brand, and Medical organizations in aligned HCOs to become the preferred partner in Alzheimer's care. Initial key accounts included Ohio State, OhioHealth, Mount Carmel, Cleveland Clinic, UH, and WVU. Executed AMYViD adoption in Cleveland and Charleston, WV markets pro bono to prepare for territory expansions and handoff to newly hired ADCs.

• Secured 1st Kisunla AIC infusion in Ohio and Ohio Valley District
• Secured 1st Kisunla HCO infusion in Ohio and Ohio Valley District
• 2024 Completed LVA Level 300 Development Program
• 2023 Platinum Performer Award Winner
• 2023 Circle of Excellence Award Winner
• 2022 National Partnership Award Winner
• Selected by ADC and LVA training to participate in Partnership Panel at Kisunla National Launch Meeting
• Selected for Dx MMT and conducted market research across multiple markets to build new AMYViD message for salesforce IVA
• Planned, executed & moderated Channel Accts/Manufacturing NBU Enterprise Knowledge Series for >140 participants for National NBeYou Team, Grow and Develop Pillar

Inaugural member of this newly established 10-person national team. Proactively engage influential stakeholders serving as both clinicians and population-based decision makers in Ohio and Washington DC markets, who impact clinical, quality, and economic determinations in the migraine space. Lead launch efforts of Lilly's migraine portfolio across Sales, MHS, Brand, and Medical organizations in key Headache Centers to become the preferred partner in comprehensive migraine care. Key accounts include Cleveland Clinic, Ohio State, Ohio Health, UC Health, and MedStar.

• Earned promotion to (S5) Senior Market Consultant in 2019
• Achieved Emgality SOM leadership in aligned accounts in 1st year of launch
• 2019 Neuroscience Partnership Award recipient for outstanding collaboration and results with DC Sales Team
• Won 2nd consecutive National Exceptional Customer Experiences Award for outstanding collaboration and customer wins
• Accepted into 2020 MHS /LVA Development Program
• Serve as Payer Liaison across national, area and local Neuro teams as well as Lilly Value Access (LVA) team
• WILL (Women’s Initiative for Leading at Lilly) Ambassador committing to empower others in elevating female voices within organization
• Lean-In Circle Leader fostering small tight-knit support group focused on networking, leadership development and career guidance

Selected to serve in new, highly competitive business unit to prepare for key launch in headache/migraine space. Responsible for maintaining previous customer base and Forteo growth metrics, while serving as district lead supporting product AMYViD in key accounts across Ohio.

• Named National Exceptional Customer Experiences Award winner for outstanding collaboration and customer wins.
• Engaged & mentored new AMYViD reps and led nationwide training calls to share best practices and real-world dialogue
• Attended WILL (Women’s Initiative for Leading at Lilly) Remote Conference focused on career development of identified top talent

Partnered with a variety of specialists, including Orthopedic, Neurosurgery, Endocrinology, OBGYN, Physical Medicine & Rehabilitation, and Primary Care customers, to build Fracture Liaison Service programs from scratch to help close the fragility fracture gap.

• Grew Forteo to exceed quota during end of brand's lifecycle while meeting all metrics across district's largest volume territory.
• Collaborated with the Field Reimbursement Manager and Specialty Pharmacy to ensure patient access and affordability for expensive biologic medication.
• Successfully turned around under-performing territory in less than 1 year to achieve and exceed portfolio sales goals, and recognized for both year-over-year NRX and TRX growth, paving the way for the District Achievement Trip.
• Selected by VP to be Inaugural Osteo Elevate Leadership Conference Ambassador to share Lilly heritage, career development, strengths essentials and diversity & inclusion principles with sales peers
• Attended MHS Women’s Network Elevate Conference focusing on mentorship, leadership and career development of top talent
• Named District Exceptional Customer Experiences Award winner for programming efforts, collaboration and customer wins
• Organized District Lilly Global Day of Service event with Indy Urban Acres Project to promote community partnership.

Promoted Cialis and Strattera to Primary Care Physicians, Psychiatrists and Pediatricians in Columbus territory representing >30% of District volume. Implemented Strategic Account Management to increase SOM for products in late-stage lifecycle, in alignment with brand strategies.

• Successfully turned around under-performing territory in less than 1 year to achieve and exceed portfolio sales goals.
• Grew Cialis SOM by 4% to establish best performance of product in territory's history and surpassing key competitor.
• Achieved multiple “All-Time High” SOM results for Cialis
• Earned District Engagement Award for outstanding leadership and sharing of best practices on vast account-based experience

Built new Columbus Imaging territory encompassing 4 states and 3 radio-pharmacies to launch first-ever Alzheimer’s imaging product AMYViD. Identified and educated new customer base, including Radiology, Nuclear Medicine, Neurology, and Imaging technologists, in both hospital and office-based settings. Major clients included Cleveland Clinic, UPMC, Ohio State, UC Health, and IU Health.

• Managed partnerships with manufacturers/distributors Cardinal Health and PET NET to secure contracting, product training and logistics for successful AMYViD implementation in key markets
• Contributed over 100 AMYViD scans in absence of Medicare coverage
• Selected to be key contributor for Alzheimer’s Customer Learning Day led by Senior Leadership and Brand team to help identify ABU strategy, reimbursement roll-out and gather customer insight to enhance vision
• A Division of Eli Lilly & Company, Indianapolis, Indiana

Selected by VP to serve as national representative on Advisory Board to aid in formation and development of new Cardiovascular Health business unit, leading to smoother transition among specialty and hospital representatives.

• Attended Zappos.com Leadership Development program and successfully incorporated 'Customer Wow' culture into CVHBU.
• Developed and implemented brand-approved Account Sales and Cath Lab Experience educational document for former specialty reps transitioning into hospital sales leading to increased access and quick impact with new customer accounts

Called upon Acute Care Intensivists, Cardiologists, Pulmonologists, Surgeons and Hospitalists to promote use of ReoPro, Effient and Xigris. Worked through formulary process with hospital pharmacies to support insulin portfolio. Major clients included Ohio State, Ohio Health, and Mount Carmel hospital systems. Consistent high performance, finishing in the top 1/3 of sales during the first 3 years of Lilly Hospital Group.

• Achieved #1 and #2 National Total Dollar Accounts for Xigris sales
• Achieved #2 National Territory Award for ReoPro sales.
• Named Lilly/Daiichi Sankyo District Peer Award Winner for outstanding Effient launch collaboration
• Earned promotion to Executive Sales Rep in 2008 and President’s Council nominations for 2006, 2007 and 2008
• Selected to attend National Sales Leadership Conference recognizing top talent
• Overcame challenging healthcare environment to drive sales for Xigris, an expensive medication to treat sepsis in critically ill patients
• Devised pathways to initiate rapid response team when patients presented with sepsis symptoms maybe qualifying for Xigris
• Launched Lilly 3ml vials and successfully converted key accounts from competitor insulin to Lilly insulin through engaging messaging and value propositions
• Collaborated with the pharmacy to capture OSU insulin business from a competitor, resulting in an additional $70,000 in sales.
• Selected as guest trainer to share best practices on hospital insulin conversions
• Launched Effient and coordinated approval on hospital formularies and availability in cardiac cath laboratories
• Revamped acute myocardial infarction protocols to include Effient as first-line treatment approach
• Named 2010 Effient Launch Goal Quest Winner

Launched and promoted multiple neuroscience products including Prozac Weekly, Strattera, Zyprexa, Symbyax and Cymbalta to over 100 Psychiatrists in private and Community Mental Health Center settings.

• Earned Top 10% Portfolio Sales in 2005 and 2006
• Achieved Top 30% status 3 times in National Cymbalta Trial Rate Program
• Awarded Top 20% Strattera Launch Winner
• Achieved #1 Territory for Zyprexa sales
• Earned Prozac Weekly Brand Team Pathfinder Award for 119% to quota.